ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 265875 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 265875; 2) Community: the network communities that were significantly associated with the response to NSC 265875; 3) Molecule: the relationships between components within communities and NSC 265875; 4) MDR: the compounds that were significantly associated with the NSC 265875.

NSC Compound Enrichment Correlation
NSC 683662 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[2-(dimethylamino)-1-oxoethoxy]-19-[(2-propenyl)amino]-, stereo 0.0115447840124334 0.24771959
NSC 683922 Null 0.0115447840124334 0.14893323
NSC 686550 Butanamide, N-(3-chloro-1,4-dioxo-2-naphthalenyl)- N-(1-oxobutyl)- 0.0115447840124334 0.020276549
NSC 691608 Null 0.0115447840124334 0.19570539
NSC 706995 Entinostat 0.0115447840124334 0.12003348
NSC 710546 Null 0.0115447840124334 0.19908999
NSC 724058 3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0115447840124334 0.14722899
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.0115447840124334 0.21397444
NSC 733465 Null 0.0115447840124334 0.15444948
NSC 749117 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline 0.0115447840124334 -0.15959968
Total:86  Current:26    [First] [Prev] [Next] [Last]